PMC Articles for MedGen (Select 44127) - PMC

Result Filters

Links from MedGen

Items: 1 to 20 of 1000

<< First< Prev

Page of 50

Select item 70761741.

Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia

Masumi Ueda, Tammy Stefan, Lindsay Stetson, James J. Ignatz-Hoover, Benjamin Tomlinson, Richard J. Creger, Brenda Cooper, Hillard M. Lazarus, Marcos de Lima, David N. Wald, Paolo F. Caimi

Front Oncol. 2020; 10: 327. Published online 2020 Mar 10. doi: 10.3389/fonc.2020.00327

PMCID:: PMC7076174

Abstract Article PDF–791K

Select item 76441512.

All-trans retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells

Chi H. Nguyen, Alexander M. Grandits, Louise E. Purton, Heinz Sill, Rotraud Wieser

Cell Cycle. 2020; 19(20): 2573–2588. Published online 2020 Sep 8. doi: 10.1080/15384101.2020.1810402

PMCID:: PMC7644151

Abstract Article PDF–6.3M

Select item 51341483.

All‐trans retinoic acid (ATRA) in non‐promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low‐dose Ara‐C in three elderly patients with NPM1‐mutated AML unfit for intensive chemotherapy and review of the literature

Fabio Forghieri, Sara Bigliardi, Chiara Quadrelli, Monica Morselli, Leonardo Potenza, Ambra Paolini, Elisabetta Colaci, Patrizia Barozzi, Patrizia Zucchini, Giovanni Riva, Daniela Vallerini, Ivana Lagreca, Roberto Marasca, Franco Narni, Adriano Venditti, Maria Paola Martelli, Brunangelo Falini, Francesco Lo Coco, Sergio Amadori, Mario Luppi

Clin Case Rep. 2016 Dec; 4(12): 1138–1146. Published online 2016 Oct 24. doi: 10.1002/ccr3.723

PMCID:: PMC5134148

Abstract Article PDF–87K

Select item 43212254.

Possible benefit of consolidation therapy with high-dose cytarabine on overall survival of adults with non-promyelocytic acute myeloid leukemia

M.C. Azevedo, E.D.R.P. Velloso, V. Buccheri, D.A.F. Chamone, P.E. Dorlhiac-Llacer

Braz J Med Biol Res. 2015 Feb; 48(2): 178–185. Published online 2014 Dec 12. doi: 10.1590/1414-431X20144059

PMCID:: PMC4321225

Abstract Article PDF–271K

Select item 92394955.

Budd-Chiari Syndrome as an Initial Presentation of Non-Promyelocytic Acute Myelogenous Leukemia

Jiten P. Kothadia, Vanisha Patel, Rajiv Heda, Wesley A. Angel, Vishwas Vanar, Benedict J. Maliakkal, Rajanshu Verma

Gastroenterology Res. 2022 Jun; 15(3): 148–154. Published online 2022 Jun 2. doi: 10.14740/gr1530

PMCID:: PMC9239495

Abstract Article PDF–2.0M

Select item 48143286.

NPM and BRG1 mediate transcriptional resistance to retinoic acid in Acute Promyelocytic Leukemia

Jessica N. Nichol, Matthew D. Galbraith, Claudia L. Kleinman, Joaquín M. Espinosa, Wilson H. Miller, Jr.

Cell Rep. Author manuscript; available in PMC 2017 Mar 29.

Published in final edited form as: Cell Rep. 2016 Mar 29; 14(12): 2938–2949. Published online 2016 Mar 17. doi: 10.1016/j.celrep.2016.02.074

PMCID:: PMC4814328

Abstract Article PDF–1.5M

Select item 47689387.

A Rare Occurrence of Simultaneous Venous and Arterial Thromboembolic Events – Lower Limb Deep Venous Thrombosis and Pulmonary Thromboembolism as Initial Presentation in Acute Promyelocytic Leukemia

Aditya S. Kutiyal, Pramila Dharmshaktu, Babita Kataria, Abhilasha Garg

Clin Med Insights Oncol. 2016; 10: 1–4. Published online 2016 Feb 25. doi: 10.4137/CMO.S37866

PMCID:: PMC4768938

Abstract Article PDF–1.5M

Select item 48230968.

A novel PAD4/SOX4/PU.1 signaling pathway is involved in the committed differentiation of acute promyelocytic leukemia cells into granulocytic cells

Guanhua Song, Lulu Shi, Yuqi Guo, Linchang Yu, Lin Wang, Xiaoyu Zhang, Lianlian Li, Yang Han, Xia Ren, Qiang Guo, Kehong Bi, Guosheng Jiang

Oncotarget. 2016 Jan 19; 7(3): 3144–3157. Published online 2015 Dec 10. doi: 10.18632/oncotarget.6551

PMCID:: PMC4823096

Abstract Article PDF–6.8M

Select item 48254439.

Erythema multiforme due to arsenic trioxide in a case of acute promyelocytic leukemia: A diagnostic challenge

Girish V. Badarkhe, Amrita Sil, Sabari Bhattacharya, Uttam Kumar Nath, Nilay Kanti Das

Indian J Pharmacol. 2016 Mar-Apr; 48(2): 216–218. doi: 10.4103/0253-7613.178827

PMCID:: PMC4825443

Abstract Article

Select item 483793210.

Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia

Federico De Angelis, Massimo Breccia

Rare Cancers Ther. 2015; 3(1): 119–132. Published online 2015 Oct 21. doi: 10.1007/s40487-015-0013-8

PMCID:: PMC4837932

Abstract Article PDF–548K

Select item 483888411.

From molecular interaction to acute promyelocytic leukemia: Calculating leukemogenesis and remission from endogenous molecular-cellular network

Ruoshi Yuan, Xiaomei Zhu, Jerald P. Radich, Ping Ao

Sci Rep. 2016; 6: 24307. Published online 2016 Apr 21. doi: 10.1038/srep24307

PMCID:: PMC4838884

Abstract Article PDF–3.3M

Select item 484041912.

Refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: A case report

Minoru Kojima, Daisuke Ogiya, Akifumi Ichiki, Ryujiro Hara, Jun Amaki, Hidetsugu Kawai, Hiroki Numata, Ai Sato, Mitsuki Miyamoto, Rikio Suzuki, Shinichiro Machida, Hiromichi Matsushita, Yoshiaki Ogawa, Hiroshi Kawada, Kiyoshi Ando

Leuk Res Rep. 2016; 5: 11–13. Published online 2016 Jan 22. doi: 10.1016/j.lrr.2016.01.001

PMCID:: PMC4840419

Abstract Article PDF–368K

Select item 484801613.

Severe Acute Axonal Neuropathy following Treatment with Arsenic Trioxide for Acute Promyelocytic Leukemia: a Case Report

Marcus Kühn, Kety Sammartin, Mitja Nabergoj, Fabrizio Vianello

Mediterr J Hematol Infect Dis. 2016; 8(1): e2016023. Published online 2016 Apr 1. doi: 10.4084/MJHID.2016.023

PMCID:: PMC4848016

Abstract Article PDF–288K

Select item 485119314.

Novel strategies in treatment of acute promyelocytic leukemia

F Lo-Coco, L Cicconi

Leukemia Suppl. 2012 Aug; 1(Suppl 2): S18–S19. Published online 2012 Aug 9. doi: 10.1038/leusup.2012.12

PMCID:: PMC4851193

Abstract Article PDF–98K

Select item 488130715.

Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin

Farhad Ravandi, Eli Estey, Dan Jones, Stefan Faderl, Susan O'Brien, Jackie Fiorentino, Sherry Pierce, Deborah Blamble, Zeev Estrov, William Wierda, Alessandra Ferrajoli, Srdan Verstovsek, Guillermo Garcia-Manero, Jorge Cortes, Hagop Kantarjian

J Clin Oncol. 2009 Feb 1; 27(4): 504–510. Published online 2008 Dec 15. doi: 10.1200/JCO.2008.18.6130

PMCID:: PMC4881307

Abstract Article PDF–144K

Select item 488275816.

New Strategies in Acute Promyelocytic Leukemia: Moving to an Entirely Oral, Chemotherapy-Free Upfront Management Approach

Amer M. Zeidan, Steven D. Gore

Clin Cancer Res. Author manuscript; available in PMC 2016 May 27.

Published in final edited form as: Clin Cancer Res. 2014 Oct 1; 20(19): 4985–4993. doi: 10.1158/1078-0432.CCR-13-2725

PMCID:: PMC4882758

Abstract Article PDF–211K

Select item 488807017.

Significance of ETV6 rearrangement in acute promyelocytic leukemia with t(15;17)/promyelocytic leukemia/retinoic acid receptor alpha

NA GAO, WEN-ZHENG YU, XUE-XIA WANG, JIAN-RONG SUN, NING YU, ZENG-YAN LIU, XIAO-DAN LIU, REN-TONG LIU, RUI FENG, BU-TONG DING, TAN SANG, NONG-JIAN GUO

Oncol Lett. 2016 Jun; 11(6): 3953–3960. Published online 2016 May 6. doi: 10.3892/ol.2016.4544

PMCID:: PMC4888070

Abstract Article PDF–722K

Select item 490695318.

Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemia

YOSHIKO AZUMA, AYA NAKAYA, MASAAKI HOTTA, SHINYA FUJITA, YUKIE TSUBOKURA, HIDEAKI YOSHIMURA, ATSUSHI SATAKE, KAZUYOSHI ISHII, TOMOKI ITO, SHOSAKU NOMURA

Mol Clin Oncol. 2016 Jul; 5(1): 31–34. Published online 2016 Apr 20. doi: 10.3892/mco.2016.864